Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Evidence - Where Are We Now?
Concato J, Corrigan-Curay J. Concato J, et al. Among authors: corrigan curay j. N Engl J Med. 2022 May 5;386(18):1680-1682. doi: 10.1056/NEJMp2200089. Epub 2022 Apr 30. N Engl J Med. 2022. PMID: 35485775 No abstract available.
Randomized, observational, interventional, and real-world-What's in a name?
Concato J, Stein P, Dal Pan GJ, Ball R, Corrigan-Curay J. Concato J, et al. Among authors: corrigan curay j. Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1514-1517. doi: 10.1002/pds.5123. Epub 2020 Sep 17. Pharmacoepidemiol Drug Saf. 2020. PMID: 32940401 No abstract available.
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
Orkin AM, Gill PJ, Ghersi D, Campbell L, Sugarman J, Emsley R, Steg PG, Weijer C, Simes J, Rombey T, Williams HC, Wittes J, Moher D, Richards DP, Kasamon Y, Getz K, Hopewell S, Dickersin K, Wu T, Ayala AP, Schulz KF, Calleja S, Boutron I, Ross JS, Golub RM, Khan KM, Mulrow C, Siegfried N, Heber J, Lee N, Kearney PR, Wanyenze RK, Hróbjartsson A, Williams R, Bhandari N, Jüni P, Chan AW; CONSERVE Group. Orkin AM, et al. JAMA. 2021 Jul 20;326(3):257-265. doi: 10.1001/jama.2021.9941. JAMA. 2021. PMID: 34152382
Breakthrough-Therapy Designation - An FDA Perspective.
Corrigan-Curay J, McKee AE, Stein P. Corrigan-Curay J, et al. N Engl J Med. 2018 Apr 12;378(15):1457-1458. doi: 10.1056/NEJMc1801222. N Engl J Med. 2018. PMID: 29641963 Free article. No abstract available.
Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care.
Adimadhyam S, Barreto EF, Cocoros NM, Toh S, Brown JS, Maro JC, Corrigan-Curay J, Dal Pan GJ, Ball R, Martin D, Nguyen M, Platt R, Li X. Adimadhyam S, et al. Among authors: corrigan curay j. J Am Soc Nephrol. 2020 Nov;31(11):2506-2516. doi: 10.1681/ASN.2020040526. Epub 2020 Oct 19. J Am Soc Nephrol. 2020. PMID: 33077615 Free PMC article. Review.
Clarifications regarding the authority and role of FDA in drug approval.
Cavaillé-Coll MW, Stein PP, Corrigan-Curay JA. Cavaillé-Coll MW, et al. Among authors: corrigan curay ja. Am J Transplant. 2020 Apr;20(4):1210-1211. doi: 10.1111/ajt.15734. Epub 2020 Jan 7. Am J Transplant. 2020. PMID: 31811778 Free article. No abstract available.
22 results